Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.

about

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.

Item

http://www.wikidata.org/entity/Q47132472

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@en

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@nl

type

Item

label

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@en

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@nl

prefLabel

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@en

Adalimumab efficacy in enterop ...... ional multidisciplinary study.

@nl

P1476

Adalimumab efficacy in enterop ...... tional multidisciplinary study

@en

P2093

Alessia Farinelli

http://www.w3.org/2001/XMLSchema#string

Armando Gabrielli

http://www.w3.org/2001/XMLSchema#string

Francesco Ciccia

http://www.w3.org/2001/XMLSchema#string

Giovanni Triolo

http://www.w3.org/2001/XMLSchema#string

Laura Bolognini

http://www.w3.org/2001/XMLSchema#string

Matteo Rossini

http://www.w3.org/2001/XMLSchema#string

Monia Ciferri

http://www.w3.org/2001/XMLSchema#string

Piergiorgio Mosca

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations.

Enteropathic spondyloarthritis: from diagnosis to treatment.

Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Rheumatic manifestations of inflammatory bowel disease.

Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?

Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.

Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients.

P304

7139-7149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I39.7139

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michele Maria Luchetti

Devis Benfaremo

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29093622

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab

P932

5656461

http://www.w3.org/2001/XMLSchema#string